Daniel M Schmitt insider trades
Open-market stock purchases and sales by Daniel M Schmitt, President, CEO and Director at Actuate Therapeutics, Inc, from SEC Form 4 filings since Aug 14, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 14, 2026 | ACTU Actuate Therapeutics, Inc | Bought (not open market) | — |
| Aug 14, 2026 | ACTU Actuate Therapeutics, Inc | Sold (not open market) | $122K |
| Aug 14, 2026 | ACTU Actuate Therapeutics, Inc | Bought (not open market) | — |
| Apr 1, 2026 | ACTU Actuate Therapeutics, Inc | Bought (not open market) | — |
| Feb 13, 2026 | ACTU Actuate Therapeutics, Inc | Bought (not open market) | — |
| Feb 13, 2026 | ACTU Actuate Therapeutics, Inc | Sold (not open market) | $528K |
Companies traded
- ACTU Actuate Therapeutics, Inc: other filings, last Aug 14, 2026